448 related articles for article (PubMed ID: 17914004)
1. Estimating Medicare Part D's impact on medication access among dually eligible beneficiaries with mental disorders.
Donohue JM; Frank RG
Psychiatr Serv; 2007 Oct; 58(10):1285-91. PubMed ID: 17914004
[TBL] [Abstract][Full Text] [Related]
2. Impact of the Medicare modernization act on dually eligible persons with psychiatric diagnoses: a New York State case study.
Jones K; Siegel C; Bertollo DN; Samuels J
Psychiatr Serv; 2009 Apr; 60(4):512-9. PubMed ID: 19339327
[TBL] [Abstract][Full Text] [Related]
3. Coverage and prior authorization of psychotropic drugs under Medicare Part D.
Huskamp HA; Stevenson DG; Donohue JM; Newhouse JP; Keating NL
Psychiatr Serv; 2007 Mar; 58(3):308-10. PubMed ID: 17325102
[TBL] [Abstract][Full Text] [Related]
4. Medicare Part D prescription drug benefits and administrative burden in the care of dually eligible psychiatric patients.
Wilk JE; West JC; Rae DS; Rubio-Stipec M; Chen JJ; Regier DA
Psychiatr Serv; 2008 Jan; 59(1):34-9. PubMed ID: 18182537
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Coverage Restrictions on Antipsychotic Utilization Among Low-Income Medicare Part D Enrollees.
Roberto PN; Brandt N; Onukwugha E; Perfetto E; Powers C; Stuart B
Adm Policy Ment Health; 2017 Nov; 44(6):943-954. PubMed ID: 28660370
[TBL] [Abstract][Full Text] [Related]
6. Cost and utilization of behavioral health medications associated with rescission of an exemption for prior authorization for severe and persistent mental illness in the Vermont Medicaid Program.
Simeone JC; Marcoux RM; Quilliam BJ
J Manag Care Pharm; 2010 Jun; 16(5):317-28. PubMed ID: 20518584
[TBL] [Abstract][Full Text] [Related]
7. First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients.
West JC; Wilk JE; Rae DS; Muszynski IL; Rubio-Stipec M; Alter CL; Sanders KE; Crystal S; Regier DA
J Clin Psychiatry; 2010 Apr; 71(4):400-10. PubMed ID: 19925748
[TBL] [Abstract][Full Text] [Related]
8. Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage.
Simoni-Wastila L; Zuckerman IH; Shaffer T; Blanchette CM; Stuart B
Health Serv Res; 2008 Apr; 43(2):496-514. PubMed ID: 18370965
[TBL] [Abstract][Full Text] [Related]
9. Medication access and continuity: the experiences of dual-eligible psychiatric patients during the first 4 months of the Medicare prescription drug benefit.
West JC; Wilk JE; Muszynski IL; Rae DS; Rubio-Stipec M; Alter CL; Narrow WE; Regier DA
Am J Psychiatry; 2007 May; 164(5):789-96. PubMed ID: 17475738
[TBL] [Abstract][Full Text] [Related]
10. Medicare Part D roulette: potential implications of random assignment and plan restrictions.
Patel RA; Walberg MP; Woelfel JA; Amaral MM; Varu P
Medicare Medicaid Res Rev; 2013; 3(2):. PubMed ID: 24753963
[TBL] [Abstract][Full Text] [Related]
11. Dual eligibles with mental disorders and Medicare part D: how are they faring?
Donohue JM; Huskamp HA; Zuvekas SH
Health Aff (Millwood); 2009; 28(3):746-59. PubMed ID: 19414883
[TBL] [Abstract][Full Text] [Related]
12. Access to Care for Medicare-Medicaid Dually Eligible Beneficiaries: The Role of State Medicaid Payment Policies.
Zheng NT; Haber S; Hoover S; Feng Z
Health Serv Res; 2017 Dec; 52(6):2219-2236. PubMed ID: 27767203
[TBL] [Abstract][Full Text] [Related]
13. Beneficiary Experience of Care by Level of Integration in Dual Eligible Special Needs Plans.
Mellor JM; Cunningham PJ; Britton E; Behrens M; Urmi AF; Vega V
JAMA Health Forum; 2024 Jun; 5(6):e241383. PubMed ID: 38848088
[TBL] [Abstract][Full Text] [Related]
14. Integration of Medicare and Medicaid for dually eligible beneficiaries: A focus group study examining beneficiaries' early experiences in California's dual financial alignment demonstration.
Graham CL; Stewart HC; Kurtovich E; Liu PJ
Disabil Health J; 2018 Jan; 11(1):130-138. PubMed ID: 29137878
[TBL] [Abstract][Full Text] [Related]
15. Clinically unintended medication switches and inability to prescribe preferred medications under Medicare Part D.
West JC; Rae DS; Mojtabai R; Rubio-Stipec M; Kreyenbuhl JA; Alter CL; Crystal S
J Psychopharmacol; 2012 Jun; 26(6):784-93. PubMed ID: 21693550
[TBL] [Abstract][Full Text] [Related]
16. Prescription drug use and expenditures among dually eligible beneficiaries.
Bagchi AD; Esposito D; Verdier JM
Health Care Financ Rev; 2007; 28(4):43-56. PubMed ID: 17722750
[TBL] [Abstract][Full Text] [Related]
17. Transition to Medicare Part D: an early snapshot of barriers experienced by younger dual eligibles with disabilities.
Hall JP; Kurth NK; Moore JM
Am J Manag Care; 2007 Jan; 13(1):14-8. PubMed ID: 17227199
[TBL] [Abstract][Full Text] [Related]
18. Racial disparities in prescription drug use among dually eligible beneficiaries.
Schore J; Brown R; Lavin B
Health Care Financ Rev; 2003; 25(2):77-90. PubMed ID: 15124379
[TBL] [Abstract][Full Text] [Related]
19. Impact of Medicare Part D on mental health treatment and outcomes for dual eligible beneficiaries with HIV.
Belenky N; Pence BW; Cole SR; Dusetzina SB; Edmonds A; Oberlander J; Plankey M; Adedimeji A; Wilson TE; Cohen J; Cohen MH; Milam JE; Adimora AA
AIDS Care; 2019 Apr; 31(4):505-512. PubMed ID: 30189747
[TBL] [Abstract][Full Text] [Related]
20. Changes in drug coverage generosity and untreated serious mental illness: transitioning from Medicaid to Medicare Part D.
Madden JM; Adams AS; LeCates RF; Ross-Degnan D; Zhang F; Huskamp HA; Gilden DM; Soumerai SB
JAMA Psychiatry; 2015 Feb; 72(2):179-88. PubMed ID: 25588123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
